Effective: March 22, 2020
Latest Legislation: Senate Bill 229 - 132nd General Assembly
(A)(1) As used in this section:
(a) "Another adult authorized to consent to the minor's medical treatment" means an adult to whom a minor's parent or guardian has given written authorization to consent to the minor's medical treatment.
(b) "Emergency facility" means a hospital emergency department or any other facility that provides emergency care.
(c) "Medical emergency" means a situation that in a prescriber's good faith medical judgment creates an immediate threat of serious risk to the life or physical health of a minor.
(d) "Minor" means an individual under eighteen years of age who is not emancipated.
(2) For purposes of this section, an individual under eighteen years of age is emancipated only if the individual has married, has entered the armed services of the United States, has become employed and self-sustaining, or otherwise has become independent from the care and control of the individual's parent, guardian, or custodian.
(B) Except as provided in division (C) of this section, before issuing for a minor the first prescription in a single course of treatment for an opioid analgesic, regardless of whether the dosage is modified during that course of treatment, a prescriber shall do all of the following:
(1) As part of the prescriber's examination of the minor, assess whether the minor has ever suffered, or is currently suffering, from mental health or substance abuse disorders and whether the minor has taken or is currently taking prescription drugs for treatment of those disorders;
(2) Discuss with the minor and the minor's parent, guardian, or another adult authorized to consent to the minor's medical treatment all of the following:
(a) The risks of addiction and overdose associated with opioid analgesics;
(b) The increased risk of addiction to controlled substances of individuals suffering from both mental health and substance abuse disorders;
(c) The dangers of taking opioid analgesics with benzodiazepines, alcohol, or other central nervous system depressants;
(d) Any other information in the patient counseling information section of the labeling for the opioid analgesic required under 21 C.F.R. 201.57(c)(18).
(3) Obtain written consent for the prescription from the minor's parent, guardian, or, subject to division (E) of this section, another adult authorized to consent to the minor's medical treatment.
The prescriber shall record the consent on a form, which shall be known as the "Start Talking!" consent form. The form shall be separate from any other document the prescriber uses to obtain informed consent for other treatment provided to the minor. The form shall contain all of the following:
(a) The name and quantity of the opioid analgesic being prescribed and the amount of the initial dose;
(b) A statement indicating that a controlled substance is a drug or other substance that the United States drug enforcement administration has identified as having a potential for abuse;
(c) A statement certifying that the prescriber discussed with the minor and the minor's parent, guardian, or another adult authorized to consent to the minor's medical treatment the matters described in division (B)(2) of this section;
(d) The number of refills, if any, authorized by the prescription;
(e) The signature of the minor's parent, guardian, or another adult authorized to consent to the minor's medical treatment and the date of signing.
(C)(1) The requirements of division (B) of this section do not apply if the minor's treatment with an opioid analgesic meets any of the following criteria:
(a) The treatment is associated with or incident to a medical emergency.
(b) The treatment is associated with or incident to surgery, regardless of whether the surgery is performed on an inpatient or outpatient basis.
(c) In the prescriber's professional judgment, fulfilling the requirements of division (B) of this section with respect to the minor's treatment would be a detriment to the minor's health or safety.
(d) Except as provided in division (D) of this section, the treatment is rendered in a hospital, emergency facility, ambulatory surgical facility, nursing home, pediatric respite care program, residential care facility, freestanding rehabilitation facility, or similar institutional facility.
(2) The requirements of division (B) of this section do not apply to a prescription for an opioid analgesic that a prescriber issues to a minor at the time of discharge from a facility or other location described in division (C)(1)(d) of this section.
(D) The exemption in division (C)(1)(d) of this section does not apply to treatment rendered in a prescriber's office that is located on the premises of or adjacent to a facility or other location described in that division.
(E) If the individual who signs the consent form required by division (B)(3) of this section is another adult authorized to consent to the minor's medical treatment, the prescriber shall prescribe not more than a single, seventy-two-hour supply and indicate on the prescription the quantity that is to be dispensed pursuant to the prescription.
(F) A signed "Start Talking!" consent form obtained under this section shall be maintained in the minor's medical record.
Structure Ohio Revised Code
Title 37 | Health-Safety-Morals
Chapter 3719 | Controlled Substances
Section 3719.01 | Controlled Substances Definitions.
Section 3719.011 | Controlled Substances Definitions for Use in Revised Code.
Section 3719.013 | Controlled Substance Analog.
Section 3719.04 | Sale of Controlled Substances by Category III Licensees.
Section 3719.05 | Pharmacist May Dispense Controlled Substances - Prescriptions - Sale of Stock.
Section 3719.06 | Authority of Licensed Health Professional.
Section 3719.061 | Prescription of Opioids to Minors.
Section 3719.062 | Adoption of Rules by Health-Related Licensing Board Regarding Opioid Analgesics.
Section 3719.063 | Liability for Administration of Naltrexone.
Section 3719.064 | Prerequisites for Initiation of Medication-Assisted Treatment.
Section 3719.07 | Record of All Controlled Substances Received, Administered, Dispensed, or Used.
Section 3719.08 | Label Required.
Section 3719.09 | Authorized Possession of Controlled Substances.
Section 3719.11 | Controlled Substances Forfeited and Destroyed.
Section 3719.13 | Inspection of Prescriptions, Orders, Records, and Stock.
Section 3719.141 | Peace Officer May Sell Controlled Substance in Performance of Official Duties.
Section 3719.16 | Dispensing of Excepted Substances.
Section 3719.161 | Prohibition Against Altering Substance to Increase Concentration.
Section 3719.172 | Possession or Sale of Hypodermics.
Section 3719.18 | Enforcement Officers - Co-Operation With Agencies.
Section 3719.19 | Persons Not Subject to Prosecution.
Section 3719.21 | Disposition of Fines and Forfeited Bail.
Section 3719.27 | Inspection and Checking of Files and Records.
Section 3719.28 | Rules for Administration and Enforcement.
Section 3719.31 | Prohibition Against Careless Distribution of Samples Containing Drug or Poison.
Section 3719.32 | Regulating the Sale of Poisons.
Section 3719.33 | Labeling Poisons.
Section 3719.34 | Provisions Inapplicable.
Section 3719.35 | Labeling and Recording of Delivery Provisions Exceptions.
Section 3719.36 | Board of Pharmacy to Enforce Poison Laws.
Section 3719.40 | Controlled Substances Included in Schedules by Designated Name.
Section 3719.41 | Controlled Substance Schedules.
Section 3719.42 | State Pharmacy Board to Meet Annually.
Section 3719.44 | Board of Pharmacy Authority to Change Schedules.
Section 3719.45 | Additions to Schedule I by Emergency Rule; Resolution.
Section 3719.61 | Opioid Treatment Programs.
Section 3719.81 | Furnishing Drug Samples.
Section 3719.811 | Sample Drug Furnished to or by Charitable Pharmacy - Exceptions.
Section 3719.812 | Qualified Immunity of Sample Drug Donors and Recipients.
Section 3719.813 | Qualified Immunity of Sample Drug Manufacturers.
Section 3719.82 | Effect of Child Support Default on License.